| MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1*♦ TE Miller, K Ghoshal, B Ramaswamy, S Roy, J Datta, CL Shapiro, S Jacob, ... Journal of biological chemistry 283 (44), 29897-29903, 2008 | 934 | 2008 |
| Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients AS Iyer, FK Jones, A Nodoushani, M Kelly, M Becker, D Slater, R Mills, ... Science immunology 5 (52), eabe0367, 2020 | 682 | 2020 |
| COVID-19-neutralizing antibodies predict disease severity and survival WF Garcia-Beltran, EC Lam, MG Astudillo, D Yang, TE Miller, J Feldman, ... Cell 184 (2), 476-488. e11, 2021 | 659 | 2021 |
| Incidence and lifetime costs of injuries in the United States P Corso, E Finkelstein, T Miller, I Fiebelkorn, E Zaloshnja Injury Prevention 12 (4), 212-218, 2006 | 567 | 2006 |
| Adaptive chromatin remodeling drives glioblastoma stem cell plasticity and drug tolerance BB Liau, C Sievers, LK Donohue, SM Gillespie, WA Flavahan, TE Miller, ... Cell stem cell 20 (2), 233-246. e7, 2017 | 471 | 2017 |
| Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo FJ Najm, M Madhavan, A Zaremba, E Shick, RT Karl, DC Factor, TE Miller, ... Nature 522 (7555), 216-220, 2015 | 412 | 2015 |
| Targeting glioma stem cells through combined BMI1 and EZH2 inhibition X Jin, LJY Kim, Q Wu, LC Wallace, BC Prager, T Sanvoranart, RC Gimple, ... Nature medicine 23 (11), 1352-1361, 2017 | 334 | 2017 |
| Preferential iron trafficking characterizes glioblastoma stem-like cells DL Schonberg, TE Miller, Q Wu, WA Flavahan, NK Das, JS Hale, ... Cancer cell 28 (4), 441-455, 2015 | 291 | 2015 |
| Test performance evaluation of SARS-CoV-2 serological assays JD Whitman, J Hiatt, CT Mowery, BR Shy, R Yu, TN Yamamoto, U Rathore, ... Nature biotechnology 38 (10), 1174, 2020 | 264 | 2020 |
| N6-methyladenine DNA modification in glioblastoma Q Xie, TP Wu, RC Gimple, Z Li, BC Prager, Q Wu, Y Yu, P Wang, Y Wang, ... Cell 175 (5), 1228-1243. e20, 2018 | 255 | 2018 |
| Evaluation of SARS-CoV-2 serology assays reveals a range of test performance JD Whitman, J Hiatt, CT Mowery, BR Shy, R Yu, TN Yamamoto, U Rathore, ... Nature biotechnology 38 (10), 1174-1183, 2020 | 245 | 2020 |
| Brain tumor stem cells: Molecular characteristics and their impact on therapy DL Schonberg, D Lubelski, TE Miller, JN Rich Molecular aspects of medicine 39, 82-101, 2014 | 226 | 2014 |
| Reciprocal signaling between glioblastoma stem cells and differentiated tumor cells promotes malignant progression X Wang, BC Prager, Q Wu, LJY Kim, RC Gimple, Y Shi, K Yang, ... Cell stem cell 22 (4), 514-528. e5, 2018 | 219 | 2018 |
| Cost of injuries from a prospective cohort study of North Carolina high school athletes SB Knowles, SW Marshall, T Miller, R Spicer, JM Bowling, D Loomis, ... Injury prevention 13 (6), 416-421, 2007 | 200 | 2007 |
| Three-dimensional bioprinted glioblastoma microenvironments model cellular dependencies and immune interactions M Tang, Q Xie, RC Gimple, Z Zhong, T Tam, J Tian, RL Kidwell, Q Wu, ... Cell research 30 (10), 833-853, 2020 | 195 | 2020 |
| Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling SC Mack, KW Pajtler, L Chavez, K Okonechnikov, KC Bertrand, X Wang, ... Nature 553 (7686), 101-105, 2018 | 195 | 2018 |
| Transcription elongation factors represent in vivo cancer dependencies in glioblastoma TE Miller, BB Liau, LC Wallace, AR Morton, Q Xie, D Dixit, DC Factor, ... Nature 547 (7663), 355-359, 2017 | 195 | 2017 |
| Purine synthesis promotes maintenance of brain tumor initiating cells in glioma X Wang, K Yang, Q Xie, Q Wu, SC Mack, Y Shi, LJY Kim, BC Prager, ... Nature neuroscience 20 (5), 661-673, 2017 | 172 | 2017 |
| Clinical sensitivity and interpretation of PCR and serological COVID‐19 diagnostics for patients presenting to the hospital TE Miller, WFG Beltran, AZ Bard, T Gogakos, MN Anahtar, MG Astudillo, ... The FASEB Journal 34 (10), 13877, 2020 | 149 | 2020 |
| Positively selected enhancer elements endow osteosarcoma cells with metastatic competence JJ Morrow, I Bayles, APW Funnell, TE Miller, A Saiakhova, MM Lizardo, ... Nature medicine 24 (2), 176-185, 2018 | 144 | 2018 |
Jeremy N. RichUniversity of PittsburghDirección de correo verificada de upmc.edu
